Ross Givens
Chief Market Strategist
Ross Givens is a veteran trader with over 15 years of experience and a former VP at a major Wall Street investment bank. Specializing in small-cap stocks and momentum-driven plays, Ross identifies high-probability setups before they hit the mainstream. As Lead Strategist at Traders Agency, he has guided hundreds of successful trades and developed multiple flagship publications.
Wall Street Is Chasing SpaceX... Smart Money Is Buying These 4 Stocks
Smart money stock picks are beating the SpaceX IPO pop. These 4 backdoor plays in AI infrastructure and oil shipping offer real upside without chasing hype
SpaceX Is Trading... Here's EXACTLY When I'd Buy and Sell
SpaceX is now trading -- here's when to buy SpaceX shares for the lowest price. Lockup expirations create a mid-August window smart traders won't miss.
SpaceX Canceled the Pullback?
The SpaceX IPO is going LIVE today. What’s going to happen next – and does the massive hype mark the “top” for the market? Find out inside.
The Government Is Erasing $39 Trillion In Debt... Here's How To Profit
The government erasing national debt through inflation is already underway. Here's how debt monetization works and which mining stocks stand to benefit mos
Does the SpaceX IPO Mark the “Top” for Tech?
The SpaceX IPO is going LIVE today. What’s going to happen next – and does the massive hype mark the “top” for the market? Find out inside.
AI Agents Are Coming... These 3 Stocks Could Go PARABOLIC
Agentic AI stocks are entering a new phase as 1.4B knowledge workers replace chatbots with autonomous agents. These 3 backdoor infrastructure plays could e
Could the SpaceX IPO End the Pullback?
The pullback continues. But the question on people’s minds is – could the SpaceX IPO end the pullback? Ross investigates.
The FDA Said NO Twice... Then Everything Changed for This $1 Stock
FDA drug rejection reversal almost never happens — but it did for Outlook Therapeutics. OTLK trades under $1 with an FDA decision due in roughly 60 days.
Could This Tech Selloff Spread to the Rest of the Market?
The tech selloff continues. Could it lead to a broader market selloff? Ross explores the situation inside.
Pullback Perspective (Must Read)
Worried about the pullback? Then you need to read this as Ross’ provides valuable perspective on the whole thing.
The SpaceX IPO Makes NO SENSE... And That's Why It Could Soar
SpaceX overvalued by half at $135 IPO price—fair value sits near $42. Here's why the momentum trade still makes sense despite the stretched valuation.
Reasons Behind the Market Plunge
Last Friday delivered the worst day of 2026 for both the Nasdaq and S&P 500 — and the “good” jobs report may be a big reason why. Payrolls came in hotter than expected, rate-hike odds jumped, and the market finally snapped after a 9-week win streak. I’ll show you why this pullback may be healthy, why it doesn’t feel that way in real time, and how I’m preparing for the next wave of breakout opportunities.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
